- Home
- UBXG vs IMA Comparison
UBXG vs IMA Comparison
Compare UBXG & IMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | UBXG | IMA |
|---|---|---|
| Founded | 2018 | 2019 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 56.0M | 65.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | UBXG | IMA |
|---|---|---|
| Price | $1.88 | $6.86 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | 4.8K | ★ 45.4K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.62 | $5.70 |
| 52 Week High | $4.60 | $17.50 |
Technical Indicators
Market Signals| Indicator | UBXG | IMA |
|---|---|---|
| Relative Strength Index (RSI) | 41.55 | 49.83 |
| Support Level | $1.72 | $6.65 |
| Resistance Level | $2.10 | $7.17 |
| Average True Range (ATR) | 0.07 | 0.39 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 11.11 | 32.25 |
Price Performance
Historical ComparisonAbout UBXG U-BX Technology Ltd. Ordinary Shares
U-BX Technology Ltd focuses on providing value-added services using artificial intelligence-driven technology to businesses in the insurance industry, including insurance carriers and brokers. Its main offerings include three services/products: digital promotion services, risk assessment services, and value-added bundled benefits. The PRC operating entities help their institutional clients gain visibility on various social media platforms and generate revenue based on consumers' clicks, views, or clients' promotion time on these channels. U-BX Beijing developed a unique algorithm named the Magic Mirror. The majority of revenue comes from digital promotion services. Geographically, all of the company's revenue is derived from Mainland China.
About IMA ImageneBio Inc.
ImageneBio Inc is a clinical-stage biopharmaceutical company that develops differentiated therapies for immunological and inflammatory (I&I) diseases. The company is focused on developing IMG-007, a non-depleting anti-OX40 monoclonal antibody, for the treatment of atopic dermatitis.